If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,643.00    -58.00 (-2.15%)
Bid:
2,632.00
Ask:
2,633.00
Spread: 1.00 (0.038%)
Market Cap: £23.44b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Annual Financial Report

6 Jun 2025 11:30

RNS Number : 8322L
Experian plc
06 June 2025
 

Experian plc

 

 

Annual Report and Accounts for the year ended 31 March 2025, Notice of Annual General Meeting 2025 and Proxy Form

 

 

6 June 2025 - Experian plc, the global data and technology company (the "Company"), hereby notifies the market, in accordance with UK Listing Rule 6.4.1(R), that the above documents are being submitted to the National Storage Mechanism and they will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Copies of the Annual Report and Accounts and the Notice of Annual General Meeting are also available on the Company's website at www.experianplc.com.

 

The 2025 Annual General Meeting of the Company will be held at The Merrion Hotel, Upper Merrion Street, Dublin 2, D02 KF79, Ireland on Wednesday 16 July 2025 at 9.30am. A summary of the resolutions and the reasons they are being proposed is set out in the explanatory notes which accompany the Notice of Annual General Meeting.

 

 

Contact:

 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSBGGDLXDGDGUL
Date   Source Headline
9th Sep 20209:22 amRNSAdditional Listing
8th Sep 20207:00 amRNSTrading update, Q2 revenue expectations revised
1st Sep 202010:25 amRNSTotal Voting Rights
28th Aug 202010:00 amRNSDirector/PDMR Shareholding
26th Aug 20209:15 amRNSAdditional Listing
19th Aug 20206:01 pmRNSExperian South Africa curtails fraud incident
19th Aug 20209:12 amRNSAdditional Listing
31st Jul 202012:55 pmRNSTotal Voting Rights
31st Jul 202012:00 pmRNSDirector/PDMR Shareholding
22nd Jul 202011:38 amRNSResult of AGM
16th Jul 20207:00 amRNSExperian PLC Trading update, first quarter
3rd Jul 20205:41 pmRNSSecond Interim Dividend
1st Jul 20202:00 pmRNSDirectorate Change
30th Jun 20202:53 pmRNSTotal Voting Rights
24th Jun 202012:25 pmRNSAdditional Listing
19th Jun 20204:40 pmRNSSecond Price Monitoring Extn
19th Jun 20204:35 pmRNSPrice Monitoring Extension
12th Jun 20202:50 pmRNSAnnual Financial Report
12th Jun 20202:20 pmRNSDirector/PDMR Shareholding
10th Jun 20203:30 pmRNSDirector/PDMR Shareholding
8th Jun 202010:35 amRNSTransaction in Own Shares
5th Jun 202012:57 pmRNSElections for second interim dividend
29th May 202012:32 pmRNSTotal Voting Rights
27th May 202011:25 amRNSAdditional Listing
20th May 20207:00 amRNSFull-year financial report
30th Apr 202012:06 pmRNSTotal Voting Rights
27th Apr 20204:22 pmRNSShare Rights – Listing Rule 9.2.6E
17th Apr 202010:15 amRNSPrice Monitoring Extension
14th Apr 20202:00 pmRNSHolding(s) in Company
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:37 pmRNSPrice Monitoring Extension
1st Apr 20209:30 amRNSBond Issue
31st Mar 202011:03 amRNSTotal Voting Rights
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 202010:59 amRNSAdditional Listing
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:36 pmRNSPrice Monitoring Extension
25th Mar 202010:44 amRNSAdditional Listing
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:35 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 20204:02 pmRNSBlock listing Interim Review
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:40 pmRNSSecond Price Monitoring Extn
13th Mar 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.